# Effects of Treprostinil on Right Ventricular Structure and Function in Patients With Pulmonary Arterial Hypertension

> **NCT03835676** · PHASE4 · UNKNOWN · sponsor: **Magdi H. Yacoub** · enrollment: 30 (estimated)

## Conditions studied

- Pulmonary Hypertension

## Interventions

- **DRUG:** Treprostinil

## Key facts

- **NCT ID:** NCT03835676
- **Lead sponsor:** Magdi H. Yacoub
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03835676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03835676, "Effects of Treprostinil on Right Ventricular Structure and Function in Patients With Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03835676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*